• CD25 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    A CD25 test is a specialized laboratory assay that measures expression of the CD25 protein, the alpha chain of the interleukin-2 (IL-2) receptor. Predominantly expressed on activated T cells, regulatory T cells (Tregs), and certain neoplastic lymphocytes, this test is commonly performed using flow cytometry or immunohistochemistry on blood, bone marrow, or tissue samples.
    It serves as a critical diagnostic tool for identifying specific hematologic malignancies, such as adult T-cell leukemia/lymphoma (ATLL) and hairy cell leukemia. Additionally, elevated CD25 levels assist in monitoring autoimmune diseases, organ transplant rejection, and systemic inflammatory conditions like hemophagocytic lymphohistiocytosis.
    A CD25 test is a specialized laboratory assay that measures expression of the CD25 protein, the alpha chain of the interleukin-2 (IL-2) receptor. Predominantly expressed on activated T cells, regulatory T cells (Tregs), and certain neoplastic lymphocytes, this test is commonly performed using flow cytometry or immunohistochemistry on blood, bone marrow, or tissue samples. It serves as a critical diagnostic tool for identifying specific hematologic malignancies, such as adult T-cell leukemia/lymphoma (ATLL) and hairy cell leukemia. Additionally, elevated CD25 levels assist in monitoring autoimmune diseases, organ transplant rejection, and systemic inflammatory conditions like hemophagocytic lymphohistiocytosis.
    0 Comments 0 Shares 3K Views 0 Reviews
  • CD23 Test New
    2,200.00₹
    In stock
    All over India
    0 Reviews
    A CD23 test is a specialized laboratory assay used to evaluate the expression of the CD23 protein, a low-affinity IgE receptor predominantly found on mature B cells, activated macrophages, and eosinophils. Commonly performed via flow cytometry or immunohistochemistry on blood or tissue samples, this test plays an important role in diagnosing and monitoring B-cell lymphoproliferative disorders, notably Chronic Lymphocytic Leukemia (CLL) where CD23 is characteristically expressed.
    Additionally, measuring soluble CD23 levels can aid in assessing allergic disease severity and inflammatory conditions, providing valuable diagnostic and prognostic insight for targeted patient management.
    A CD23 test is a specialized laboratory assay used to evaluate the expression of the CD23 protein, a low-affinity IgE receptor predominantly found on mature B cells, activated macrophages, and eosinophils. Commonly performed via flow cytometry or immunohistochemistry on blood or tissue samples, this test plays an important role in diagnosing and monitoring B-cell lymphoproliferative disorders, notably Chronic Lymphocytic Leukemia (CLL) where CD23 is characteristically expressed. Additionally, measuring soluble CD23 levels can aid in assessing allergic disease severity and inflammatory conditions, providing valuable diagnostic and prognostic insight for targeted patient management.
    0 Comments 0 Shares 3K Views 0 Reviews
  • CD22 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    A CD22 test is a specialized diagnostic assay used to detect the CD22 protein, a surface marker found primarily on normal and malignant B lymphocytes. Typically performed using flow cytometry or immunohistochemistry on blood, bone marrow, or tissue samples, this test plays a vital role in diagnosing and classifying B-cell malignancies, such as B-cell acute lymphoblastic leukemia (ALL) and certain non-Hodgkin lymphomas.
    By identifying CD22 expression, healthcare providers can determine a patient's eligibility for targeted therapies—including antibody-drug conjugates and CAR-T cell treatments—helping to guide personalized cancer care and monitor treatment response.
    A CD22 test is a specialized diagnostic assay used to detect the CD22 protein, a surface marker found primarily on normal and malignant B lymphocytes. Typically performed using flow cytometry or immunohistochemistry on blood, bone marrow, or tissue samples, this test plays a vital role in diagnosing and classifying B-cell malignancies, such as B-cell acute lymphoblastic leukemia (ALL) and certain non-Hodgkin lymphomas. By identifying CD22 expression, healthcare providers can determine a patient's eligibility for targeted therapies—including antibody-drug conjugates and CAR-T cell treatments—helping to guide personalized cancer care and monitor treatment response.
    0 Comments 0 Shares 3K Views 0 Reviews
  • CD2 by flow Cytometry Blood test New
    2,390.00₹
    In stock
    All over India
    0 Reviews
    The CD2 by Flow Cytometry (Blood) test evaluates the presence and proportion of CD2 surface markers on peripheral blood lymphocytes. CD2 is a key co-stimulatory glycoprotein expressed on mature T cells and Natural Killer (NK) cells, playing an essential role in cell adhesion and immune activation.
    Using fluorescently labeled antibodies, flow cytometry precisely analyzes single cells to quantify T-cell populations. Clinicians order this test to help diagnose and monitor primary immunodeficiencies, T-cell acute lymphoblastic leukemia (T-ALL), T-cell lymphomas, and other lymphoproliferative disorders. It also assists in tracking immune reconstitution following bone marrow or hematopoietic stem cell transplantation.
    The CD2 by Flow Cytometry (Blood) test evaluates the presence and proportion of CD2 surface markers on peripheral blood lymphocytes. CD2 is a key co-stimulatory glycoprotein expressed on mature T cells and Natural Killer (NK) cells, playing an essential role in cell adhesion and immune activation. Using fluorescently labeled antibodies, flow cytometry precisely analyzes single cells to quantify T-cell populations. Clinicians order this test to help diagnose and monitor primary immunodeficiencies, T-cell acute lymphoblastic leukemia (T-ALL), T-cell lymphomas, and other lymphoproliferative disorders. It also assists in tracking immune reconstitution following bone marrow or hematopoietic stem cell transplantation.
    0 Comments 0 Shares 5K Views 0 Reviews
  • CD 19 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    The CD19 test is a specialized blood test that measures the percentage and absolute number of CD19-positive B lymphocytes in your immune system. CD19 is a key surface biomarker found exclusively on B cells, which are responsible for producing antibodies to fight infections.
    Clinicians primary use this test to monitor and evaluate immune deficiencies, autoimmune disorders, and blood cancers like chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma. It is also crucial for tracking patient response and immune system recovery during targeted immunotherapy treatments, such as anti-CD19 CAR-T cell therapy or targeted monoclonal antibody drugs like rituximab.
    The CD19 test is a specialized blood test that measures the percentage and absolute number of CD19-positive B lymphocytes in your immune system. CD19 is a key surface biomarker found exclusively on B cells, which are responsible for producing antibodies to fight infections. Clinicians primary use this test to monitor and evaluate immune deficiencies, autoimmune disorders, and blood cancers like chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma. It is also crucial for tracking patient response and immune system recovery during targeted immunotherapy treatments, such as anti-CD19 CAR-T cell therapy or targeted monoclonal antibody drugs like rituximab.
    0 Comments 0 Shares 5K Views 0 Reviews
  • CD 15 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    The CD15 test is a diagnostic laboratory evaluation used in hematopathology to detect expression of the CD15 cell-surface carbohydrate antigen (3-fucosyl-N-acetyllactosamine). Expressed prominently on mature neutrophils, eosinophils, and monocytes, CD15 serves as an important marker in immunophenotyping.
    Conducted via immunohistochemistry or flow cytometry on blood, bone marrow, or tissue biopsies, this test is critical for diagnosing Classical Hodgkin Lymphoma, where CD15 is typically positive on characteristic Reed-Sternberg cells. It also aids in identifying granulocytic differentiation in Acute Myeloid Leukemia (AML). Evaluating CD15 expression assists clinicians in accurate cancer subtyping, staging, and determining optimal targeted therapies.
    The CD15 test is a diagnostic laboratory evaluation used in hematopathology to detect expression of the CD15 cell-surface carbohydrate antigen (3-fucosyl-N-acetyllactosamine). Expressed prominently on mature neutrophils, eosinophils, and monocytes, CD15 serves as an important marker in immunophenotyping. Conducted via immunohistochemistry or flow cytometry on blood, bone marrow, or tissue biopsies, this test is critical for diagnosing Classical Hodgkin Lymphoma, where CD15 is typically positive on characteristic Reed-Sternberg cells. It also aids in identifying granulocytic differentiation in Acute Myeloid Leukemia (AML). Evaluating CD15 expression assists clinicians in accurate cancer subtyping, staging, and determining optimal targeted therapies.
    0 Comments 0 Shares 8K Views 0 Reviews
  • CD 14 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    The CD14 test is a diagnostic evaluation in hematopathology used to detect the CD14 cell-surface protein, a key co-receptor for bacterial lipopolysaccharide (LPS). Expressed heavily on monocytes and macrophages, CD14 serves as a primary marker for identifying monocytic cell lineages.
    Conducted via flow cytometry on peripheral blood or bone marrow samples, this test helps clinicians distinguish monocytic leukemias from other myeloid and lymphoid malignancies. It is particularly valuable for diagnosing Acute Monocytic Leukemia (AML-M5) and Chronic Myelomonocytic Leukemia (CMML). Detecting CD14 expression provides essential insights for accurate disease classification, prognostic assessment, and guiding targeted treatment strategies.
    The CD14 test is a diagnostic evaluation in hematopathology used to detect the CD14 cell-surface protein, a key co-receptor for bacterial lipopolysaccharide (LPS). Expressed heavily on monocytes and macrophages, CD14 serves as a primary marker for identifying monocytic cell lineages. Conducted via flow cytometry on peripheral blood or bone marrow samples, this test helps clinicians distinguish monocytic leukemias from other myeloid and lymphoid malignancies. It is particularly valuable for diagnosing Acute Monocytic Leukemia (AML-M5) and Chronic Myelomonocytic Leukemia (CMML). Detecting CD14 expression provides essential insights for accurate disease classification, prognostic assessment, and guiding targeted treatment strategies.
    0 Comments 0 Shares 8K Views 0 Reviews
  • CD 13 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    The CD13 test is a diagnostic laboratory evaluation used in hematopathology to detect the expression of the CD100/CD13 surface protein, also known as Aminopeptidase N. Naturally expressed on mature and immature myeloid cells, CD13 serves as an essential marker for lineage identification.
    Conducted using flow cytometry or immunohistochemistry on blood or bone marrow samples, the test helps pathologists differentiate myeloid lineage leukemias from lymphoid malignancies. It is particularly vital for diagnosing Acute Myeloid Leukemia (AML) and identifying myeloid differentiation in acute leukemias. Ultimately, detecting CD13 assists clinicians in precise cancer subtyping, determining prognosis, and planning targeted therapeutic strategies.
    The CD13 test is a diagnostic laboratory evaluation used in hematopathology to detect the expression of the CD100/CD13 surface protein, also known as Aminopeptidase N. Naturally expressed on mature and immature myeloid cells, CD13 serves as an essential marker for lineage identification. Conducted using flow cytometry or immunohistochemistry on blood or bone marrow samples, the test helps pathologists differentiate myeloid lineage leukemias from lymphoid malignancies. It is particularly vital for diagnosing Acute Myeloid Leukemia (AML) and identifying myeloid differentiation in acute leukemias. Ultimately, detecting CD13 assists clinicians in precise cancer subtyping, determining prognosis, and planning targeted therapeutic strategies.
    0 Comments 0 Shares 8K Views 0 Reviews
  • CD 10 Test New
    2,600.00₹
    In stock
    All over India
    0 Reviews
    The CD10 test is a diagnostic laboratory evaluation used in hematopathology to identify the CD10 protein, also known as Common Acute Lymphoblastic Leukemia Antigen (CALLA). Expressed on pre-B lymphocytes and germinal center B-cells, CD10 serves as a key cell-surface marker.
    Using flow cytometry or immunohistochemistry on blood, bone marrow, or lymph node samples, the test helps clinicians distinguish specific lymphomas and leukemias. It is particularly crucial for diagnosing Pre B-cell Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma, and Burkitt Lymphoma. Ultimately, detecting CD10 expression aids doctors in precise cancer subtyping, risk stratification, and selecting targeted treatment plans.
    The CD10 test is a diagnostic laboratory evaluation used in hematopathology to identify the CD10 protein, also known as Common Acute Lymphoblastic Leukemia Antigen (CALLA). Expressed on pre-B lymphocytes and germinal center B-cells, CD10 serves as a key cell-surface marker. Using flow cytometry or immunohistochemistry on blood, bone marrow, or lymph node samples, the test helps clinicians distinguish specific lymphomas and leukemias. It is particularly crucial for diagnosing Pre B-cell Acute Lymphoblastic Leukemia (ALL), Follicular Lymphoma, and Burkitt Lymphoma. Ultimately, detecting CD10 expression aids doctors in precise cancer subtyping, risk stratification, and selecting targeted treatment plans.
    0 Comments 0 Shares 8K Views 0 Reviews
  • CD 5 Test New
    2,390.00₹
    In stock
    All over India
    0 Reviews
    The CD5 test is a diagnostic evaluation used in pathology and hematology to detect the expression of the CD5 protein on immune cells. CD5 is a cell-surface marker naturally present on mature T-lymphocytes and a small subset of B-lymphocytes.
    Performed via flow cytometry or immunohistochemistry on blood, bone marrow, or tissue biopsies, the test helps clinicians distinguish and classify specific blood cancers. Abnormal expression of CD5 on B-cells strongly points toward conditions like Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma. Ultimately, this test plays a vital role in accurate cancer staging, guiding targeted therapies, and monitoring treatment response.
    The CD5 test is a diagnostic evaluation used in pathology and hematology to detect the expression of the CD5 protein on immune cells. CD5 is a cell-surface marker naturally present on mature T-lymphocytes and a small subset of B-lymphocytes. Performed via flow cytometry or immunohistochemistry on blood, bone marrow, or tissue biopsies, the test helps clinicians distinguish and classify specific blood cancers. Abnormal expression of CD5 on B-cells strongly points toward conditions like Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma. Ultimately, this test plays a vital role in accurate cancer staging, guiding targeted therapies, and monitoring treatment response.
    0 Comments 0 Shares 8K Views 0 Reviews
  • 🇷🇺🇺🇸 Russia's President Vladimir Putin received in the Kremlin Special Envoy of the President of the United States of America Steve Witkoff and entrepreneur, founder of Affinity Partners Jared Kushner (Moscow, September 5, 2026)


    💬 Vladimir Putin: Colleagues, I heartily welcome you to Moscow.


    The situation we are to sort out today is, of course, a difficult one.


    But before we begin, I would like to ask you to convey my best wishes and words of gratitude to the President of the United States, Donald Trump.


    While he realizes that he is facing a difficult situation, he nevertheless does not stop his efforts to resolve it and to contribute to the settlement of the Russian‑Ukrainian conflict. Today, we will discuss all its components and all its aspects, and for our part, we are also ready to inform you about our view of the situation.


    As you informed us, I know that you are planning to go to Kiev after visiting Moscow. In any case, of course, no matter what happens next, contacts of this kind are certainly always beneficial.


    And here, of course, the quality of mediation and trust in those who are engaged in it are very important. I’d like to tell you that we find it comfortable to work with you, and, of course, we have a very high level of trust during this work.


    🤝 We are glad to see you. Welcome.


    ***


    We received the request through official channels — both through the intelligence services and through the Ministry of Foreign Affairs — to stop the strikes on Kiev. I issued the respective order, and since midnight on September 5, these strikes on Kiev have not been carried out.


    I would like to note that the Ukrainian side has also significantly reduced — by an order of magnitude — the strikes on the territory of the Russian Federation, including Moscow.


    The Ukrainian authorities have published their **** for a broader three‑day truce, but we have never agreed on this with them.


    Yet we will do everything in our power to ensure the safety of the negotiation process and the mediators, represented by you and, perhaps, by those accompanying you.


    #RussiaUS
    🇷🇺🇺🇸 Russia's President Vladimir Putin received in the Kremlin Special Envoy of the President of the United States of America Steve Witkoff and entrepreneur, founder of Affinity Partners Jared Kushner (Moscow, September 5, 2026) 💬 Vladimir Putin: Colleagues, I heartily welcome you to Moscow. The situation we are to sort out today is, of course, a difficult one. But before we begin, I would like to ask you to convey my best wishes and words of gratitude to the President of the United States, Donald Trump. While he realizes that he is facing a difficult situation, he nevertheless does not stop his efforts to resolve it and to contribute to the settlement of the Russian‑Ukrainian conflict. Today, we will discuss all its components and all its aspects, and for our part, we are also ready to inform you about our view of the situation. As you informed us, I know that you are planning to go to Kiev after visiting Moscow. In any case, of course, no matter what happens next, contacts of this kind are certainly always beneficial. And here, of course, the quality of mediation and trust in those who are engaged in it are very important. I’d like to tell you that we find it comfortable to work with you, and, of course, we have a very high level of trust during this work. 🤝 We are glad to see you. Welcome. *** We received the request through official channels — both through the intelligence services and through the Ministry of Foreign Affairs — to stop the strikes on Kiev. I issued the respective order, and since midnight on September 5, these strikes on Kiev have not been carried out. I would like to note that the Ukrainian side has also significantly reduced — by an order of magnitude — the strikes on the territory of the Russian Federation, including Moscow. The Ukrainian authorities have published their call for a broader three‑day truce, but we have never agreed on this with them. Yet we will do everything in our power to ensure the safety of the negotiation process and the mediators, represented by you and, perhaps, by those accompanying you. #RussiaUS
    0 Comments 0 Shares 2K Views 13 0 Reviews
  • Bone marrow Aspiration - slide for review New
    850.00₹
    In stock
    All over India
    0 Reviews
    The bone marrow aspiration slide review is a critical diagnostic procedure used to evaluate hematopoiesis and identify cellular abnormalities. During this test, a stained smear of bone marrow fluid is examined under a microscope by a pathologist or hematologist.
    The evaluation focuses on cellularity, the myeloid-to-erythroid ratio, and the maturation stages of different blood cell lineages. Key indicators such as blast percentages, atypical cells, and iron stores are assessed to diagnose conditions like leukemias, myelodysplastic syndromes, and anemias. This detailed microscopic analysis provides essential data for accurate diagnosis, staging, and therapeutic monitoring.
    The bone marrow aspiration slide review is a critical diagnostic procedure used to evaluate hematopoiesis and identify cellular abnormalities. During this test, a stained smear of bone marrow fluid is examined under a microscope by a pathologist or hematologist. The evaluation focuses on cellularity, the myeloid-to-erythroid ratio, and the maturation stages of different blood cell lineages. Key indicators such as blast percentages, atypical cells, and iron stores are assessed to diagnose conditions like leukemias, myelodysplastic syndromes, and anemias. This detailed microscopic analysis provides essential data for accurate diagnosis, staging, and therapeutic monitoring.
    0 Comments 0 Shares 3K Views 0 Reviews
More Results